Aditxt, Inc. Debt Instrument, Fee Amount
Aditxt, Inc. (ADTX) had Debt Instrument, Fee Amount of $240.00 thousand as of 2023-10-05, per its 10-K filed 2024-04-16.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2024-04-16
- 2023-10-05: Debt Instrument, Fee Amount $240.00K.
- 2023-08-23: Debt Instrument, Fee Amount $70.00K.
- 2023-05-30: Debt Instrument, Fee Amount $100.00K.
- 2023-04-24: Debt Instrument, Fee Amount $60.00K.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2023-10-05 | $240.00K 10-K · filed 2024-04-16 |
| 2023-08-23 | $70.00K 10-K · filed 2024-04-16 |
| 2023-05-30 | $100.00K 10-K · filed 2024-04-16 |
| 2023-04-24 | $60.00K 10-K · filed 2024-04-16 |
| 2023-04-04 | $60.00K 10-K · filed 2024-04-16 |
| 2023-02-21 | $75.00K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |